Trial Profile
Effects on immune cell function and phenotype following treatment with blinatumomab in children with relapsed b-cell precursor acute lymphoblastic leukaemia.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 Aug 2014
Price :
$35
*
At a glance
- Drugs Blinatumomab (Primary)
- Indications Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Pharmacodynamics
- 13 Aug 2014 New trial record